Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.32USD
20 Jul 2018
Change (% chg)

$-0.07 (-2.06%)
Prev Close
$3.39
Open
$3.38
Day's High
$3.41
Day's Low
$3.31
Volume
27,951
Avg. Vol
37,913
52-wk High
$4.56
52-wk Low
$3.00

Select another date:

Mon, Feb 5 2018

BRIEF-Nymox Announces U.S. NDA For Fexapotide For BPH

* SAYS ‍RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR FEXAPOTIDE FOR BPH​ WILL BE SUBMITTED LATER IN 2018 Source text for Eikon: Further company coverage:

BRIEF-Nymox Reports 5-Yr Results From Prostate Cancer Study Of Fexapotide Triflutate In 146 U.S. Men

* NYMOX REPORTS 5-YEAR RESULTS FROM PROSPECTIVE RANDOMIZED CONTROLLED PROSTATE CANCER STUDY OF FEXAPOTIDE TRIFLUTATE IN 146 U.S. MEN

Select another date: